ADTX heads into its May 1 earnings report as one of the most aggressively shorted small names on Nasdaq, caught in a spiral of accelerating bearish positioning and a stock down nearly 70% in a month.
The short interest picture here is extreme, even by micro-cap standards. Short interest as a percentage of free float has exploded to 45.4%, having risen more than 2,700% over the past month alone. The spike is sharp and recent — shorts held barely 8,959 shares in mid-March before surging past 348,000 in late April. Yet despite this surge in borrowed stock, utilization has actually eased to 38%, well below its 52-week peak of nearly 96% reached in March. That drop in utilization alongside higher short interest suggests new shares became available to borrow — likely via fresh share issuance or a change in lending pool dynamics. Borrowing still costs a punishing 228% annualised, though that rate has eased from above 300% earlier in April. The ORTEX short score sits at 76, placing ADTX firmly in the top quartile of bearish positioning across the market.
The fundamental picture offers little for bulls to hold onto. No analyst consensus, no published revenue estimates, and no meaningful valuation multiples are available — the company's market cap barely clears $250,000 at current prices. The RSI14 is at 18.76, deep in oversold territory, which might attract very short-term technical traders, but there is no fundamental floor visible in the public data. The EV reading is negative, reflecting a company whose cash or liabilities structure puts enterprise value below zero. Institutional ownership is almost entirely composed of algorithmic market makers — Hudson River Trading holds nearly 15% of shares but added virtually its entire stake in a single week ending April 21, a marker of market-making activity rather than conviction investment.
Historical earnings reactions add to the cautious backdrop. The last confirmed earnings event, on February 13, produced a 12% one-day drop and a 27% decline over the following five days. A March 31 announcement saw a one-day bounce of 14%, but that gave way to a 34% loss over the subsequent week. The pattern is consistent: even short-lived rallies around announcements have been unwound rapidly. Peers ALPS and CELZ are both down on the week, though neither is experiencing comparable short pressure, making ADTX's setup stand apart from its correlated names rather than reflecting a sector-wide move.
The May 1 print is less a binary catalyst and more a test of whether any development — clinical, financial, or structural — can break the pattern of post-announcement selling that has defined this stock's recent history.
See the live data behind this article on ORTEX.
Open ADTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
